CDNA
CareDx, Inc
NASDAQ · USHealthcareMedical - Diagnostics & Research
$38.37-3.42%
Price as of Jul 20, 2026
CDNA financials
CareDx, Inc financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $379.8M | $333.8M | $280.3M | $321.8M |
| Cost of revenue | $125.4M | $109.6M | $102.0M | $112.2M |
| Gross profit | $254.4M | $224.2M | $178.3M | $209.6M |
| Operating expenses | $275.4M | $183.4M | $381.7M | $286.8M |
| Operating income | -$21.0M | $40.8M | -$203.4M | -$77.2M |
| Net income | -$21.4M | $52.5M | -$190.3M | -$76.6M |
| EBITDA | -$667.0K | -$34.0M | -$84.9M | -$60.2M |
| Basic EPS | $-0.40 | $1.00 | $-3.54 | $-1.44 |
| Diluted EPS | $-0.40 | $0.93 | $-3.54 | $-1.44 |
| Balance sheet | ||||
| Cash & equivalents | $65.4M | $114.7M | $82.2M | $89.9M |
| Total assets | $413.2M | $491.1M | $466.8M | $543.0M |
| Total liabilities | $110.1M | $112.6M | $205.5M | $112.1M |
| Stockholders’ equity | $303.1M | $378.4M | $261.3M | $430.9M |
| Total debt | $26.2M | $28.4M | $34.2M | $39.0M |
| Net debt | -$39.2M | -$86.3M | -$48.0M | -$50.9M |
| Cash flow | ||||
| Operating cash flow | $42.0M | $38.0M | -$18.4M | -$25.2M |
| Capital expenditure | -$5.9M | -$6.5M | -$9.2M | -$24.3M |
| Free cash flow | $36.1M | $31.6M | -$27.6M | -$49.6M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | -$87.8M | -$522.0K | -$27.5M | -$642.0K |